![Jun Yi Dai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 13 M $ al 31/08/2026
Jun Yi Dai is currently Chairman & Chief Executive Officer at Indaptus Therapeutics, Inc. starting in 2026, Independent Director at Mega Matrix Corp.
since 2024, and Managing Director at FLMD Pty Ltd. since 2015.
Former roles include Independent Director at Mega Matrix, Inc. Education includes an undergraduate degree from The University of New South Wales.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/06/2026 | 11.250.000 ( 9,93 % ) | 13 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Director Ejecutivo | 23/03/2026 |
Mega Matrix Corp.
 Mega Matrix Corp. MiscellaneousMiscellaneous Functions as an investment holding company | Director/Miembro de la Junta | 10/05/2024 |
| Empresas | Cargo | Fin |
|---|
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Mega Matrix Corp.
Mega Matrix Corp. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indaptus Therapeutics, Inc.
 Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
